1. Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes. (18th April 2013) Authors: Bollyky, J. B.; Long, S. A.; Fitch, M.; Bollyky, P. L.; Rieck, M.; Rogers, R.; Samuels, P. L.; Sanda, S.; Buckner, J. H.; Hellerstein, M. K.; Greenbaum, C. J. Journal: Clinical and experimental immunology Issue: Volume 172:Number 3(2013:Jun.) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Identifying the 'Achilles heel' of type 1 diabetes. (22nd February 2021) Authors: Battaglia, M.; Buckner, J. H.; Levings, M. K.; Richardson, S. J.; Wong, F. S.; Tree, T. I. Journal: Clinical and experimental immunology Issue: Volume 204:Number 2(2021) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Peripheral and Site‐Specific CD4+CD28null T Cells from Rheumatoid Arthritis Patients Show Distinct Characteristics. (February 2014) Authors: Pieper, J.; Johansson, S.; Snir, O.; Linton, L.; Rieck, M.; Buckner, J. H.; Winqvist, O.; van, R.; Malmström, V. Journal: Scandinavian journal of immunology Issue: Volume 79:Number 2(2014:Feb.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗